SCHEMBL10169845

SCHEMBL10169845

CCCN1CC(Oc2ccc(C(=O)c3c(-c4ccccc4)noc3-c3ccc(O)cc3)cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.44
PTGS1 P23219 1/20 0.42
KDM4E B2RXH2 2/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
GRIN1 Q05586 2/20 0.39
GRIN2B Q13224 2/20 0.39
S1PR1 P21453 6/20 0.38
S1PR3 Q99500 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
SCD O00767 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
ALOX12 P18054 1/20 0.37
HTT P42858 1/20 0.37
MMP3 P08254 1/20 0.37
ACACB O00763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9956555 0.99 ESR1 (0.43) ESR1PTGS1KDM4EMAPTATM
SCHEMBL10169693 0.90 ESR1 (0.43) ESR1KDM4EMAPTATMGRIN1
SCHEMBL10169847 0.90 ESR1 (0.43) ESR1MAPTGRIN1GRIN2BS1PR1
SCHEMBL9957139 0.89 ESR1 (0.43) ESR1MAPTGRIN1GRIN2BS1PR1
Hydrochloric Acid SCHEMBL9956790 0.89 ESR1 (0.43) ESR1KDM4EMAPTATMGRIN1
SCHEMBL9956546 0.89 ESR1 (0.43) ESR1MAPTS1PR1S1PR3MEN1
Hydrochloric Acid SCHEMBL9957448 0.89 ESR1 (0.43) ESR1MAPTGRIN1GRIN2BS1PR1
Hydrochloric Acid SCHEMBL9956229 0.88 ESR1 (0.42) ESR1MAPTS1PR1S1PR3MEN1
SCHEMBL10169843 0.88 ESR1 (0.42) ESR1GRIN1GRIN2BS1PR1S1PR3
SCHEMBL10169723 0.88 ESR1 (0.42) ESR1MAPTGRIN1GRIN2BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540361-B2 N-substituted azetidine derivatives MERCK SHARP & DOHME B.V. (NL) 2017-01-10 US disclosed
US-9540361-B2 N-substituted azetidine derivatives MERCK SHARP & DOHME B.V. (NL) 2017-01-10 US disclosed
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2016-05-12 US disclosed
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2016-05-12 US disclosed
WO-2012084711-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MSD OSS B.V. (NL) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES ESR2, ESR1, GPER1 ESR1 2/4885PTGS1 314/4885KDM4E 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.